Primary care excluded from drug deal because GPs and commissioners cannot be trusted
Primary care will continue to be denied access to drugs whose price has been reduced as part of a deal between government and the pharmaceutical industry because “commissioners, doctors and pharmacists” cannot be trusted with confidential information about costs, according to an NHS England policy note.
You need to be signed in to read more
Subscribe for unlimited access
With a HSJ subscription you’ll unlock:
- All of HSJ.co.uk and our HSJ mobile app
- News and insight on all areas of public funded healthcare
- Expert commentary, insight and analysis from industry leaders
- 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics